{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:05Z","timestamp":1707524825757},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"DOI":"10.7759\/cureus.32353","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T18:00:46Z","timestamp":1670608846000},"source":"Crossref","is-referenced-by-count":0,"title":["Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy"],"prefix":"10.7759","author":[{"given":"Georgios P","family":"Dividis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios  E","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Karageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Kotronis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO coronavirus (COVID-19) dashboard. (2022). Accessed. November 14, 2022: https:\/\/covid19.who.int\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa247","article-title":"A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias","volume":"71","author":"Zhao D","year":"2020","unstructured":"Zhao D, Yao F, Wang L, et al.. A comparative study on the clinical features of coronavirus 2019 (COVID-19) pneumonia with other pneumonias. Clin Infect Dis. 2020, 71:756-61. 10.1093\/cid\/ciaa247","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu L","year":"2020","unstructured":"Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020, 40:998-1004. 10.1111\/liv.14435","journal-title":"Liver Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19 - final report","volume":"383","author":"Beigel JH","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, et al.. Remdesivir for the treatment of COVID-19 - final report. N Engl J Med. 2020, 383:1813-26. 10.1056\/NEJMoa2007764","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019, 70:1222-61. 10.1016\/j.jhep.2019.02.014","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2016.00022","article-title":"Hypoxic hepatitis: a review and clinical update","volume":"4","author":"Waseem N","year":"2016","unstructured":"Waseem N, Chen PH. Hypoxic hepatitis: a review and clinical update. J Clin Transl Hepatol. 2016, 4:263-8. 10.14218\/JCTH.2016.00022","journal-title":"J Clin Transl Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang C","year":"2020","unstructured":"Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020, 5:428-30. 10.1016\/S2468-1253(20)30057-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.08.064","article-title":"A systematic review and meta-analysis of the COVID-19 associated liver injury","volume":"19","author":"Wong YJ","year":"2020","unstructured":"Wong YJ, Tan M, Zheng Q, et al.. A systematic review and meta-analysis of the COVID-19 associated liver injury. Ann Hepatol. 2020, 19:627-34. 10.1016\/j.aohep.2020.08.064","journal-title":"Ann Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe COVID-19","volume":"383","author":"Goldman JD","year":"2020","unstructured":"Goldman JD, Lye DC, Hui DS, et al.. Remdesivir for 5 or 10 days in patients with severe COVID-19. N Engl J Med. 2020, 383:1827-37. 10.1056\/NEJMoa2015301","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang JT","year":"2004","unstructured":"Wang JT, Sheng WH, Fang CT, et al.. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004, 10:818-24. 10.3201\/eid1005.030640","journal-title":"Emerg Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa883","article-title":"Drug-induced liver injury in a patient with coronavirus disease 2019: potential interaction of remdesivir with P-glycoprotein inhibitors","volume":"72","author":"Leegwater E","year":"2021","unstructured":"Leegwater E, Strik A, Wilms EB, Bosma LB, Burger DM, Ottens TH, van Nieuwkoop C. Drug-induced liver injury in a patient with coronavirus disease 2019: potential interaction of remdesivir with P-glycoprotein inhibitors. Clin Infect Dis. 2021, 72:1256-8. 10.1093\/cid\/ciaa883","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2464","article-title":"Acetylcysteine for the treatment of suspected remdesivir-associated acute liver failure in COVID-19: a case series","volume":"40","author":"Carothers C","year":"2020","unstructured":"Carothers C, Birrer K, Vo M. Acetylcysteine for the treatment of suspected remdesivir-associated acute liver failure in COVID-19: a case series. Pharmacotherapy. 2020, 40:1166-71. 10.1002\/phar.2464","journal-title":"Pharmacotherapy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2016150207","article-title":"Imaging findings of congestive hepatopathy","volume":"36","author":"Wells ML","year":"2016","unstructured":"Wells ML, Fenstad ER, Poterucha JT, et al.. Imaging findings of congestive hepatopathy. Radiographics. 2016, 36:1024-37. 10.1148\/rg.2016150207","journal-title":"Radiographics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(78)90819-7","article-title":"Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug","volume":"65","author":"Hepner GW","year":"1978","unstructured":"Hepner GW, Vesell ES, Tantum KR. Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug. Am J Med. 1978, 65:371-6. 10.1016\/0002-9343(78)90819-7","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1975.tb00552.x","article-title":"Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure","volume":"2","author":"Tokola O","year":"1975","unstructured":"Tokola O, Pelkonen O, Karki NT, Luoma P. Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure. Br J Clin Pharmacol. 1975, 2:429-36. 10.1111\/j.1365-2125.1975.tb00552.x","journal-title":"Br J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/124956-remdesivir-induced-liver-injury-in-a-patient-with-coronavirus-disease-2019-and-history-of-congestive-hepatopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:55Z","timestamp":1707507895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/124956-remdesivir-induced-liver-injury-in-a-patient-with-coronavirus-disease-2019-and-history-of-congestive-hepatopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.32353","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}